Laman UtamaARWR • NASDAQ
add
Arrowhead Pharmaceuticals Inc
$11.35
Selepas Waktu Dagangan:(0.00%)0.00
$11.35
Tutup: 16 Apr, 4:35:18 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$12.87
Julat hari
$11.00 - $12.75
Julat tahun
$9.57 - $30.41
Permodalan pasaran
1.56B USD
Bilangan Purata
1.92J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 2.50J | -29.60% |
Perbelanjaan pengendalian | 163.91J | 17.00% |
Pendapatan bersih | -173.08J | -30.27% |
Margin untung bersih | -6.92K | -85.04% |
Pendapatan bagi setiap syer | -1.39 | -12.10% |
EBITDA | -156.18J | -18.06% |
Kadar cukai berkesan | -0.06% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 550.84J | 158.15% |
Jumlah aset | 1.01B | 61.86% |
Jumlah liabiliti | 957.62J | 111.59% |
Jumlah ekuiti | 56.08J | — |
Syer tertunggak | 126.10J | — |
Harga kepada buku | 30.64 | — |
Pulangan pada aset | -37.48% | — |
Pulangan pada modal | -40.94% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -173.08J | -30.27% |
Tunai daripada operasi | -146.27J | -24.13% |
Tunai daripada pelaburan | 76.91J | 18.62% |
Tunai daripada pembiayaan | 20.63J | 7,628.09% |
Perubahan bersih dalam tunai | -48.80J | 7.37% |
Aliran tunai bebas | -114.43J | 33.38% |
Perihal
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
Diasaskan
1 Jan 2004
Ibu pejabat
Tapak web
Pekerja
609
